Biosynex SA (EPA:ALBIO)

Biosynex Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.32	8.46	4.69	20.17	87.17	132.03
Short-Term Investments	-	-	5	6	-	-
Cash & Short-Term Investments	9.32	8.46	9.69	26.16	87.17	132.03
Cash Growth	-4.54%	-12.75%	-62.96%	-69.99%	-33.98%	258.43%
Accounts Receivable	10.78	7.82	7.1	10.65	14.7	25.27
Other Receivables	17.08	12.68	6.81	5.84	14.09	6.08
Receivables	27.86	20.49	13.91	16.49	28.79	31.35
Inventory	20	22.87	32.67	38.21	37.67	31.15
Prepaid Expenses	-	1.54	1.91	-	1.43	1.05
Other Current Assets	0	2.04	1.66	4.83	3.35	2.27
Total Current Assets	57.18	55.56	64.39	91.35	159.61	198.78
Property, Plant & Equipment	6.7	8.5	11.82	11.94	6.38	3.44
Long-Term Investments	0.13	0.37	0.6	0.47	2.57	3.28
Goodwill	-	-	64.13	91.54	60.91	46.24
Other Intangible Assets	64.36	69.24	20.71	21.76	25.95	5.89
Long-Term Deferred Charges	-	-	28.11	16.36	-	-
Other Long-Term Assets	3.02	2.56	4.92	8.3	4.93	11.31
Total Assets	131.4	136.24	194.69	241.73	260.34	268.94

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	17.56	17.15	16.31	15.07	14.99	18.73
Accrued Expenses	-	6	4.92	6.19	6.62	7.64
Short-Term Debt	-	-	-	0.24	0.04	0.04
Current Portion of Long-Term Debt	-	60.8	-	-	49.48	0.15
Current Portion of Leases	-	0.46	-	-	1.41	-
Current Income Taxes Payable	-	2.86	5.14	0.01	1.73	19.81
Current Unearned Revenue	-	0.14	0.22	0.51	0.22	1.94
Other Current Liabilities	-	0.02	-	9.17	8.36	12.45
Total Current Liabilities	17.56	87.42	26.6	31.19	83.86	61.32
Long-Term Debt	62.86	-	62.63	63.88	1.15	34.08
Long-Term Leases	-	0.39	-	1.84	-	1.04
Long-Term Deferred Tax Liabilities	-	1.13	6.6	3.48	-	-
Other Long-Term Liabilities	19.49	10.42	14.56	17.02	8.43	4.69
Total Liabilities	99.91	99.35	110.38	117.41	93.45	101.14

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.88	1.88	1.08	1.08	1.03	1.11
Additional Paid-In Capital	32.78	32.78	25.6	25.6	25.6	47.27
Retained Earnings	-4.15	-58.22	-43.33	55.31	77.08	130.92
Comprehensive Income & Other	0.98	60.45	101.06	42.49	58.83	-11.5
Total Common Equity	31.49	36.89	84.4	124.48	162.53	167.81
Minority Interest	-	-	-0.08	-0.17	4.37	-
Shareholders' Equity	31.49	36.89	84.31	124.32	166.9	167.81
Total Liabilities & Equity	131.4	136.24	194.69	241.73	260.34	268.94

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	62.86	61.65	62.63	65.96	52.08	35.31
Net Cash (Debt)	-53.54	-53.19	-52.94	-39.8	35.1	96.72
Net Cash Growth	-	-	-	-	-63.71%	359.13%
Net Cash Per Share	-2.84	-2.89	-4.92	-3.72	3.41	9.31
Filing Date Shares Outstanding	18.86	18.43	18.75	10.76	10.25	10.32
Total Common Shares Outstanding	18.86	18.43	10.76	10.76	10.25	10.32
Working Capital	39.63	-31.86	37.8	60.16	75.75	137.45
Book Value Per Share	1.67	2.00	7.84	11.57	15.85	16.26
Tangible Book Value	-32.87	-32.35	-0.45	11.18	75.67	115.67
Tangible Book Value Per Share	-1.74	-1.76	-0.04	1.04	7.38	11.21
Buildings	-	-	3.87	3.13	-	-
Machinery	-	-	24.48	31.4	10.58	6.37
Construction In Progress	-	-	0	0.02	0.03	-

Data Source: S&P Global Market Intelligence Last updated: May 7, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 4, 2026

Data Sources Report a data error